Last Updated on October 15, 2024 by The Health Master
Drug recall
What’s Drug Recall:
- Product: Cefdinir for Oral Suspension (250 mg/5 mL)
- Company: Lupin Pharmaceuticals, Inc. (US arm of Lupin)
- Reason for Drug Recall: Defective containers lacking seal integrity, posing a potential health risk.
- Number of Bottles Recalled: 51,006
- Date of Drug Recall Initiation: May 8, 2024
- USFDA Classification: Class II Nationwide Voluntary Drug Recall
What is Cefdinir Oral Suspension?
Cefdinir is a generic antibiotic medication prescribed to treat various bacterial infections.
It comes in a liquid form (suspension) for oral consumption.
Why is the Drug Recall?
The US Food and Drug Administration (USFDA) reports that Lupin Pharmaceuticals, Inc. is recalling over 51,000 bottles of Cefdinir Oral Suspension due to defective containers.
These containers lack proper seal integrity, which could lead to:
- Contamination of the medication
- Reduced effectiveness of the medication
- Potential allergic reactions
Who Should Be Aware of the Drug Recall?
- Patients taking Cefdinir Oral Suspension (250 mg/5 mL)
- Healthcare professionals who prescribe or dispense Cefdinir
- Parents or caregivers administering Cefdinir to children
What to Do if You Have the Recalled Medication
- Stop using the medication immediately.
- Contact your pharmacist or healthcare provider for guidance on returning the recalled product and obtaining a safe replacement.
- Report any adverse reactions you experienced while using the medication to the USFDA.
Lupin’s Manufacturing and Distribution
Lupin is a major player in the global pharmaceutical industry, with India being the world’s largest supplier of generic medicines.
Here’s a quick breakdown of Lupin’s reach:
- Manufacturing: Mandideep plant in India
- Marketing and Distribution (US): Baltimore-based Lupin Pharmaceuticals, Inc.
- Global Market Share: Approximately 20% of generic medicines worldwide
- Product Range: Over 60,000 generic brands across 60 therapeutic categories
- Export Destinations: Over 200 countries, including major markets like Japan, Australia, Western Europe, and the US
Maintaining Patient Safety
Medication safety is paramount. This Drug recall highlights the importance of ongoing vigilance in manufacturing and quality control processes.
Patients are advised to stay informed about potential drug recall and to consult their healthcare providers for any questions or concerns.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
Drug recall: Dr Reddy’s, Sun Pharma, Aurobindo recall these drugs due to this reason
Drug recall: Cipla, Glenmark recall these drugs
Drug recall: This Dietary Supplement recalled due to the Presence of Nortadalafil
Drug recall: 7 lots of Treprostinil injection recalled due to this reason
Drug Recall: Sapropterin Dihydrochloride Recalled Over Potency Concerns
NPPA to recalculate ceiling price of Rheumatoid Arthritis Drug
New Schedule M: Impact on Cosmetic Manufacturing
DCGI approval granted for this new Antibiotic Drug Combination
Gujarat FDCA Cracks Down on Medical Stores: Licenses cancelled
Gujarat FDCA Cracks Down on Pharmaceutical Manufacturing Violations
CDSCO Panel Approves Benralizumab Solution For Injection In Auto-Injector
BIS Standards for Medical Device Testing in India
NABL Clarifies Test Method for Blood-Resistant PPE
Govt issues instructions on marketing codes of pharma companies
Nutraceuticals in Drug Units: Panel to examine the issue
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
